WASHINGTON, April 30 -- Nuclear Regulatory Commission has issued a notice called: In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Direct and Indirect Transfers of License.
The notice was published in the Federal Register on April 30 by Michael Balazik, Senior Project Manager, Non-Power Production and Utilization Facility Licensing Branch, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, Office of Nuclear Reactor Regulation.
Summary: The U.S. Nuclear Regulatory Commission (NRC) is issuing an order approving the license transfer application filed by SHINE Technologies, LLC, dated February 4, 2026, as supplemented on April 13, 2026. Specifically, the order approves the di...